Research / ACCS / Fundamental state Inspectable configuration
State dimensions Filing 0001654954-23-014030 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
263.02% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.20% · OPTIONAL · VALID
Operating cash generation 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
3.79% · OPTIONAL · VALID
Revenue growth 90th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
43.35% · CORE · VALID
Gross margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
76.26% · CORE · VALID
Operating margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
7.83% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.68% · OPTIONAL · VALID
SBC intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.74% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 70 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/8 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 7/8 normalized Level 3 Dec 31, 2024 6/7 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.06%
Current 0.20%
Delta 0.14% Cash Generation Decreased
Previous 17.94%
Current 3.79%
Delta -14.14% Growth Decreased
Previous 66.20%
Current 43.35%
Delta -22.84% Margin Increased
Previous 75.80%
Current 76.26%
Delta 0.46% Profitability Decreased
Previous 18.10%
Current 7.83%
Delta -10.27% R And D Intensity Increased
Previous 5.51%
Current 7.68%
Delta 2.16% Sbc Intensity Increased
Previous 3.67%
Current 4.74%
Delta 1.07% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.